291 related articles for article (PubMed ID: 28089481)
1. Recommendations for MRI-based contouring of gross tumor volume and organs at risk for radiation therapy of pancreatic cancer.
Heerkens HD; Hall WA; Li XA; Knechtges P; Dalah E; Paulson ES; van den Berg CAT; Meijer GJ; Koay EJ; Crane CH; Aitken K; van Vulpen M; Erickson BA
Pract Radiat Oncol; 2017; 7(2):126-136. PubMed ID: 28089481
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging (MRI) compared with computed tomography (CT) for interobserver agreement of gross tumor volume delineation in pancreatic cancer: a multi-institutional contouring study on behalf of the AIRO group for gastrointestinal cancers.
Caravatta L; Cellini F; Simoni N; Rosa C; Niespolo RM; Lupattelli M; Picardi V; Macchia G; Sainato A; Mantello G; Dionisi F; Rosetto ME; Fusco V; Navarria F; De Paoli A; Guido A; Vecchi C; Basilico R; Cianci R; Delli Pizzi A; Di Nicola M; Mattiucci GC; Valentini V; Morganti AG; Genovesi D
Acta Oncol; 2019 Apr; 58(4):439-447. PubMed ID: 30632876
[TBL] [Abstract][Full Text] [Related]
3. Variability of target and normal structure delineation using multimodality imaging for radiation therapy of pancreatic cancer.
Dalah E; Moraru I; Paulson E; Erickson B; Li XA
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):633-40. PubMed ID: 24755533
[TBL] [Abstract][Full Text] [Related]
4. MRI-based high-precision irradiation in an orthotopic pancreatic tumor mouse model : A treatment planning study.
Dobiasch S; Kampfer S; Habermehl D; Duma MN; Felix K; Strauss A; Schilling D; Wilkens JJ; Combs SE
Strahlenther Onkol; 2018 Oct; 194(10):944-952. PubMed ID: 29947818
[TBL] [Abstract][Full Text] [Related]
5. Triphasic contrast enhanced CT simulation with bolus tracking for pancreas SBRT target delineation.
Godfrey DJ; Patel BN; Adamson JD; Subashi E; Salama JK; Palta M
Pract Radiat Oncol; 2017; 7(6):e489-e497. PubMed ID: 28666905
[TBL] [Abstract][Full Text] [Related]
6. Mapping patterns of local recurrence after pancreaticoduodenectomy for pancreatic adenocarcinoma: a new approach to adjuvant radiation field design.
Dholakia AS; Kumar R; Raman SP; Moore JA; Ellsworth S; McNutt T; Laheru DA; Jaffee E; Cameron JL; Tran PT; Hobbs RF; Wolfgang CL; Herman JM
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1007-15. PubMed ID: 24267969
[TBL] [Abstract][Full Text] [Related]
7. Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer.
Ng M; Leong T; Chander S; Chu J; Kneebone A; Carroll S; Wiltshire K; Ngan S; Kachnic L
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1455-62. PubMed ID: 22401917
[TBL] [Abstract][Full Text] [Related]
8. Glioma consensus contouring recommendations from a MR-Linac International Consortium Research Group and evaluation of a CT-MRI and MRI-only workflow.
Tseng CL; Stewart J; Whitfield G; Verhoeff JJC; Bovi J; Soliman H; Chung C; Myrehaug S; Campbell M; Atenafu EG; Heyn C; Das S; Perry J; Ruschin M; Sahgal A
J Neurooncol; 2020 Sep; 149(2):305-314. PubMed ID: 32860571
[TBL] [Abstract][Full Text] [Related]
9. Retroperitoneal Sarcoma Target Volume and Organ at Risk Contour Delineation Agreement Among NRG Sarcoma Radiation Oncologists.
Baldini EH; Abrams RA; Bosch W; Roberge D; Haas RLM; Catton CN; Indelicato DJ; Olsen JR; Deville C; Chen YL; Finkelstein SE; DeLaney TF; Wang D
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1053-1059. PubMed ID: 26194680
[TBL] [Abstract][Full Text] [Related]
10. Consequences of additional use of contrast-enhanced (18)F-FDG PET/CT in target volume delineation and dose distribution for pancreatic cancer.
Li XX; Liu NB; Zhu L; Yuan XK; Yang CW; Ren P; Gong LL; Zhao LJ; Xu WG; Wang P
Br J Radiol; 2015 Jul; 88(1051):20140590. PubMed ID: 25939819
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy technical considerations in the management of locally advanced pancreatic cancer: American-French consensus recommendations.
Huguet F; Goodman KA; Azria D; Racadot S; Abrams RA
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1355-64. PubMed ID: 22768988
[TBL] [Abstract][Full Text] [Related]
12. The utility of multimodality imaging with CT and MRI in defining rectal tumour volumes for radiotherapy treatment planning: a pilot study.
Tan J; Lim Joon D; Fitt G; Wada M; Lim Joon M; Mercuri A; Marr M; Chao M; Khoo V
J Med Imaging Radiat Oncol; 2010 Dec; 54(6):562-8. PubMed ID: 21199435
[TBL] [Abstract][Full Text] [Related]
13. MRI-Based Upper Abdominal Organs-at-Risk Atlas for Radiation Oncology.
Lukovic J; Henke L; Gani C; Kim TK; Stanescu T; Hosni A; Lindsay P; Erickson B; Khor R; Eccles C; Boon C; Donker M; Jagavkar R; Nowee ME; Hall WA; Parikh P; Dawson LA
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):743-753. PubMed ID: 31953061
[TBL] [Abstract][Full Text] [Related]
14. Radiation Therapy Oncology Group consensus panel guidelines for the delineation of the clinical target volume in the postoperative treatment of pancreatic head cancer.
Goodman KA; Regine WF; Dawson LA; Ben-Josef E; Haustermans K; Bosch WR; Turian J; Abrams RA
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):901-8. PubMed ID: 22483737
[TBL] [Abstract][Full Text] [Related]
15. Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA): employing dose-volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicity.
Landry JC; Yang GY; Ting JY; Staley CA; Torres W; Esiashvili N; Davis LW
Med Dosim; 2002; 27(2):121-9. PubMed ID: 12074463
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic gross tumor volume contouring on computed tomography (CT) compared with magnetic resonance imaging (MRI): Results of an international contouring conference.
Hall WA; Heerkens HD; Paulson ES; Meijer GJ; Kotte AN; Knechtges P; Parikh PJ; Bassetti MF; Lee P; Aitken KL; Palta M; Myrehaug S; Koay EJ; Portelance L; Ben-Josef E; Erickson BA
Pract Radiat Oncol; 2018; 8(2):107-115. PubMed ID: 29426692
[TBL] [Abstract][Full Text] [Related]
17. In Silico Trial of MR-Guided Midtreatment Adaptive Planning for Hypofractionated Stereotactic Radiation Therapy in Centrally Located Thoracic Tumors.
Henke LE; Kashani R; Hilliard J; DeWees TA; Curcuru A; Przybysz D; Green O; Robinson CG; Bradley JD
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):987-995. PubMed ID: 29953910
[TBL] [Abstract][Full Text] [Related]
18. Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: national guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group.
Nielsen MH; Berg M; Pedersen AN; Andersen K; Glavicic V; Jakobsen EH; Jensen I; Josipovic M; Lorenzen EL; Nielsen HM; Stenbygaard L; Thomsen MS; Vallentin S; Zimmermann S; Offersen BV;
Acta Oncol; 2013 May; 52(4):703-10. PubMed ID: 23421926
[TBL] [Abstract][Full Text] [Related]
19. IMRT for prostate cancer: defining target volume based on correlated pathologic volume of disease.
Teh BS; Bastasch MD; Wheeler TM; Mai WY; Frolov A; Uhl BM; Lu HH; Carpenter LS; Chiu JK; McGary J; Woo SY; Grant WH; Butler EB
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):184-91. PubMed ID: 12694837
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
